(Q43451486)

23 November 2017

title

Progress and challenges in bacterial meningitis (English)

1 reference

23 November 2017

1 reference

Diederik van de Beek

1

0 references

language of work or name

English

0 references

publication date

1 November 2012

1 reference

23 November 2017

1 reference

23 November 2017

volume

380

1 reference

23 November 2017

issue

9854

1 reference

23 November 2017

page(s)

1623-1624

1 reference

Clinical features and prognostic factors in adults with bacterial meningitis

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Community-acquired bacterial meningitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Dilemmas in the diagnosis of acute community-acquired bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Advances in treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Effect of vaccines on bacterial meningitis worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Dexamethasone in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Pathogenesis and pathophysiology of pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

A call for transparent reporting to optimize the predictive value of preclinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961808-X

7 January 2021

10.1016/S0140-6736(12)61808-X

Identifiers

DOI

1 reference

23 November 2017

1 reference